Research keywords (5)：
泌尿器科学
, gene therapy
, Auticarer drug resistance
, chemotherapy
, Urology
Research theme for competitive and other funds (35)：
2022 - 2025 Development of new diagnostic method of bladder cancer based on mRNA derived from urine exosome
2021 - 2024 がんと腫瘍血管の相互作用による新たな転移促進機構の解明とその制御
2021 - 2024 The effect of steroid for calcineurin inhibitors nephrotoxicity in kidney transplant recipients
2021 - 2024 Development of immunomonitoring system that predicts chronic antibody-mediated rejection in kidney transplant recipients
2021 - 2024 Motion analysis of laparoscopic surgical skills in experts and its use for surgical education
2020 - 2023 Impact of behavioral sexual dimorphism and fetal endocrinological status on establishment of bladder and bowel control in children
2018 - 2021 Development of an immunological monitoring system to predict chronic rejection in kidney transplant recipients.
2018 - 2021 Development of the new system to appropriately assess health related quality of life in patients with bladder cancer survivor using patient reported outcome.
2018 - 2021 Development of an algorithm for risk of chronic antibody-mediated rejection after kidney transplant assessed by human leukocyte antigen structure-based histocompatibility
2017 - 2020 Effects of prenatal exposure to endocrine disruption chemicals on gonadal function and sexual dimorphism
2017 - 2020 The control of castration resistant prostate cancer (CRPC) through degradation of androgen receptor splice variant by dioxins
2017 - 2020 Targeting urothelial cancer by inhibiting drug transporter of tumor blood vessels
2017 - 2020 Continuous training system for developing highly competent endoscopic surgeons
2014 - 2017 Development of "Ubiquitin" -targeted Prostate cancer treatment
2014 - 2017 Inhibition of prostatic cancer through degradation of androgen receptor by effects of dioxin receptor ligand
2014 - 2017 Prediction of cancer metastasis by tumor endothelial secreting proteins
2014 - 2017 Application of tumor endothelial derived exosomal-miRNA for cancer diagnosis and therapy.
2014 - 2017 Building the high-reliability surgical team by use of previous medical incidents reports
2011 - 2013 Development of novel therapy for refractory prostatic cancer through degradation of androgen receptor by effects of dioxins
2011 - 2013 Discovery of diagonositc and therapeutic biomarker by circulating tumor endothelial cells in metastatic renal cell carcinoma
2008 - 2010 Development of new screening system for anti-angiogenic drugs using tumor associated endothelial cells derived from renal cell carcinoma
2005 - 2006 In vivo imaging with replication competent retrovirus vector in urologic cancer
2005 - 2006 Analysis of Mechanism of Adrenal Regeneration
2003 - 2004 Analysis of expression pattern of the gene which is related to the radiation sensitivity in urothelial cancer and its clinical application
2001 - 2003 Elucidation of protective effects of phytochemicals on hormone-related cancer
2000 - 2001 Establishment of gene therapy against bladder cancer utilizing gelsolin gene and a dominant negative ras mutant
1999 - 2000 Basic study for the prevention of recurrence by inhibition of cell adhesion and migration in superficial bladder cancer.
1999 - 2000 Gene target therapy against human bladder cancer by gelsolin gene
1998 - 1999 Preclinical study for gene therapy against bladder cancer utilizing gelsolin gene and a dominant negative ras mutant
1996 - 1997 Growth suppression of renal cell carcinoma cell lines by a dominant negative H-ras mutant
1996 - 1997 Establishment of Method of Detecting Early Prostate Carcinoma by Classification of lsozyme Pattern of Prostate Specific Antigen.
1993 - 1993 ras癌遺伝子発現細胞におけるシスプラチン耐性機構と臨床への応用
1993 - 1993 シスプラチン耐性におけるras癌遺伝子の役割とその克服
泌尿器科癌に対する新規抗癌剤を用いた全身化学療法の開発
Development of systemic chemotherapy utilizing novel anti-cancer drugs against the urological cancers
Show all
Papers (811)：
Miho Sato, Takahiro Osawa, Kentaro Nishioka, Tomohiko Miyazaki, Shuhei Takahashi, Takashi Mori, Takayuki Hashimoto, Haruka Miyata, Ryuji Matsumoto, Takashige Abe, et al. Decision regret after curative treatment and its association with the decision-making process and quality of life for prostate cancer patients. International journal of urology : official journal of the Japanese Urological Association. 2024
Naoya Iwahara, Kiyohiko Hotta, Takayuki Hirose, Hiromi Okada, Nobuo Shinohara. Protocol biopsy of kidney allograft enables early detection of BK virus nephropathy to preserve kidney allograft function. Transplant Infectious Disease. 2024
Naoto Wakabayashi, Shiro Watanabe, Takashige Abe, Junki Takenaka, Kenji Hirata, Rina Kimura, Keita Sakamoto, Nobuo Shinohara, Kohsuke Kudo. Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysis. Annals of nuclear medicine. 2024. 38. 7. 553-562
大澤崇宏, 宮田遥, 松本隆児, 安部崇重, 篠原信雄. Importance of health-related quality of life in the pharmacotherapy of patients with renal cancer. 日本泌尿器科学会総会(Web). 2024. 111th
安部崇重, 宮田遥, 松本隆児, 大澤崇宏, 菊地央, 篠原信雄. Open retroperitoneal lymph node dissection for testicular cancer: Surgical education of open surgery in ”Robotics” era. 泌尿器外科. 2024. 37
日本癌治療学会
, 泌尿器科 分子・治療研究会
, 泌尿器 分子・治療研究会
, 尿路癌治療研究会
, 日本泌尿器科学会がん登録推進委員会
, 日本泌尿器科学会
, 日本内分泌外科学会
, 日本癌学会
, 米国泌尿器科学会
, 米国癌治療学会
, American Society of Clinical Oncology
, American Urological Association
, Japanese Endocrine Surgery association
, Japanese Clinical Cancer Society
, Japanese Cancer Society
, Japanese Urological Association
